#United States #West Chester #Centinel Spine #prodisc #Total Disc Replacement

Centinel Spine's Prodisc Achieves Record Success in 2024

Centinel Spine®, a leader in the global medical device market, has celebrated a remarkable achievement with its prodisc® Total Disc Replacement (TDR) system, recording over $95 million in revenue for the full year of 2024. This figure represents a significant increase of 38% compared to the previous year, showcasing the growing demand for their innovative spinal solutions.

In both the U.S. and international markets, prodisc TDR sales broke records across various product segments. The U.S. market experienced a notable 41% increase in sales, while international sales rose by 24% year-over-year (YOY). Both cervical and lumbar segments saw impressive growth, with cervical sales increasing by 39% and lumbar sales by 35% YOY.

Fourth Quarter Highlights

The fourth quarter of 2024 proved to be particularly strong for Centinel Spine, with prodisc TDR revenue soaring to nearly $30 million, marking an impressive 47% YOY growth. In more detail, prodisc Cervical revenue reached almost $17 million, a 38% YOY increase, while prodisc Lumbar revenue surged by 62%, nearing $13 million. This growth is reflective of the rising interest and adoption of TDR solutions in treating spinal diseases.

The U.S. market alone achieved record sales of over $25 million, a remarkable 52% increase from the previous year, and the international revenue reached $4.6 million, reflecting a 27% YOY growth.

Year in Review: 2024 Highlights

For the entirety of 2024, Centinel Spine recorded impressive statistics:

• - Total worldwide prodisc TDR revenue exceeded $95 million, up 38% YOY.
• - Cervical revenue surpassed $59 million, marking a 39% increase.
• - Lumbar revenue approached $36 million, up by 35% YOY.
• - In the U.S., prodisc TDR revenue was nearly $77 million, a 41% YOY increase.
• - The number of surgeons utilizing prodisc devices in the U.S. reached over 1,100, a substantial growth of 44% from the previous year, alongside over 1,000 U.S. healthcare facilities adopting prodisc implants.
• - Internationally, TDR revenue exceeded $18 million, reflecting a growth of 24% YOY.

Advancements in Technology and Offerings

In addition to impressive revenue metrics, Centinel Spine has also demonstrated success with its new Match-the-Disc™ prodisc Cervical TDR system. Since its limited release in Q3 2022, over 9,000 procedures have been completed in the U.S., leading to a 46% increase in prodisc Cervical revenue for 2024. This increase includes a commitment to training more than 800 surgeons through their global Medical Education program.

The company has also successfully onboarded an average of 100 new surgeon users to the Match-the-Disc system each quarter, significantly enhancing the system's usage among U.S. surgeons, with over 900 now regularly using the prodisc Cervical technology.

Looking Ahead to 2025

As Centinel Spine moves into 2025, the company is well-positioned for continued expansion. The notable increase in demand for TDR solutions, fueled by patient awareness and education, is expected to maintain momentum. Additionally, the recent positive coverage decisions from payors in the U.S. will help facilitate patient access to the prodisc Lumbar TDR system, which is crucial for growth.

According to Centinel Spine CEO Steve Murray, the company's ongoing commitment to total disc replacement has set them on a clear path toward leadership in this rapidly growing market segment. In his words, "We are all-in on total disc replacement and well-positioned for continued success in 2025 and beyond."

All these factors combine to solidify the prodisc technology’s status as a leader in the spine care domain, validated by an extensive body of clinical research supporting its effectiveness and durability. Centinel Spine continues to innovate and enhance its offerings to ensure the best outcomes for patients suffering from spinal diseases, and the future looks bright for this pioneering company.